Protalix BioTherapeutics (PLX) Institutional Ownership $2.39 -0.04 (-1.65%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.41 +0.02 (+0.84%) As of 02/21/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$2.99MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$412.95K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC73,940$139K0.0%+33.4%0.100% 2/17/2025 Point72 Asia Singapore Pte. Ltd.53,507$101K0.0%+13.7%0.073% 2/17/2025 Millennium Management LLC387,921$729K0.0%+3.8%0.527% 2/17/2025 Cubist Systematic Strategies LLC29,307$55K0.0%+24.1%0.040% 2/17/2025 Bank of America Corp DE33,714$63K0.0%-25.1%0.046% 2/14/2025 Jane Street Group LLC113,616$214K0.0%+147.2%0.154% 2/14/2025 Northern Trust Corp731,742$1.38M0.0%+1,299.4%0.994% 2/13/2025 Marshall Wace LLP101,899$192K0.0%N/A0.138% 2/13/2025 Renaissance Technologies LLC1,118,000$2.10M0.0%+17.0%1.518% 2/11/2025 Prudential Financial Inc.36,400$68K0.0%N/A0.049% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/11/2025 Virtu Financial LLC34,276$64K0.0%-21.0%0.047% 2/4/2025 Y Intercept Hong Kong Ltd18,818$35K0.0%N/A0.026% 1/22/2025 PFG Investments LLC20,730$39K0.0%N/A0.028% 11/25/2024 Sanctuary Advisors LLC37,100$38K0.0%N/A0.050% 11/20/2024 Virtu Financial LLC43,388$44K0.0%N/A0.059% 11/15/2024 XTX Topco Ltd35,058$36K0.0%N/A0.048% 11/15/2024 Jane Street Group LLC45,952$47K0.0%-84.2%0.062% 11/15/2024 Point72 Asia Singapore Pte. Ltd.47,073$48K0.0%-30.9%0.064% 11/5/2024 GSA Capital Partners LLP435,213$444K0.0%+8.5%0.592% 9/16/2024 Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 9/16/2024 Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/15/2024 AQR Capital Management LLC57,106$67K0.0%N/A0.078% 8/15/2024 Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/14/2024 Squarepoint Ops LLC137,764$161K0.0%+673.3%0.188% 8/14/2024 Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 8/9/2024 Renaissance Technologies LLC804,600$941K0.0%-2.4%1.097% 8/8/2024 Ground Swell Capital LLC62,234$73K0.1%N/A0.085% 5/20/2024 Virtu Financial LLC157,516$198K0.0%N/A0.215% 5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029% 5/3/2024 GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673% 2/2/2024 Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023 GSA Capital Partners LLP496,781$825K0.1%N/A0.694% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023 Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% 10/24/2023 Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023 Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023 Natixis132,000$264K0.0%N/A0.202% Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y8/4/2023 American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023 Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023 Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023 Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022 Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022 Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022 Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021 GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070% 8/18/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021 Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021 Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021 Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021 Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021 Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021 XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021 Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% 8/5/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 5/19/2021 Virtu Financial LLC27,744$124K0.0%N/A0.061% 5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821% 5/17/2021 Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197% 5/17/2021 DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655% 5/14/2021 Laurion Capital Management LP42,813$191K0.0%N/A0.094% 5/14/2021Credit Suisse AG10,000$45K0.0%N/A0.022% 5/13/2021 Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119% 5/10/2021 Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538% 5/7/2021 D.A. Davidson & CO.130,700$583K0.0%N/A0.288% 4/30/2021 Ground Swell Capital LLC14,684$65K0.2%N/A0.032% 4/28/2021 DAVENPORT & Co LLC12,000$54K0.0%N/A0.026% 2/17/2021 Jane Street Group LLC22,218$81K0.0%+51.5%0.067% 2/16/2021 Squarepoint Ops LLC22,068$80K0.0%-50.6%0.066% 2/4/2021 GSA Capital Partners LLP10,042$36K0.0%N/A0.030% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 29 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($2.10M), Northern Trust Corp ($1.38M), Millennium Management LLC ($729K), GSA Capital Partners LLP ($444K), Connor Clark & Lunn Investment Management Ltd. ($278K), Bank of New York Mellon Corp ($275K), and Natixis ($264K).Learn more on PLX's institutional investors. What percentage of Protalix BioTherapeutics stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics stock? Of the 28 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Northern Trust Corp ($679.45K), GSA Capital Partners LLP ($530.75K), Connor Clark & Lunn Investment Management Ltd. ($210.70K), Virtu Financial LLC ($200.90K), Renaissance Technologies LLC ($162.10K), Point72 Asia Singapore Pte. Ltd. ($142.76K), and Squarepoint Ops LLC ($138.47K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 3,230,736 shares in the last 24 months. This purchase volume represents approximately $3.48M in transactions. Which Protalix BioTherapeutics major shareholders have been selling company stock? The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: Jane Street Group LLC ($244.31K), GSA Capital Partners LLP ($50.67K), Point72 Asia Singapore Pte. Ltd. ($21.09K), Renaissance Technologies LLC ($20.10K), Denali Advisors LLC ($15.50K), SG Americas Securities LLC ($13.14K), and Bank of America Corp DE ($11.28K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 385,195 shares in the last 24 months. This volume of shares sold represents approximately $440.54K in transactions. Related Companies Nuvation Bio Major Shareholders Prothena Major Shareholders Cronos Group Major Shareholders GH Research Major Shareholders Bicara Therapeutics Major Shareholders Verve Therapeutics Major Shareholders Mind Medicine (MindMed) Major Shareholders Dianthus Therapeutics Major Shareholders Anavex Life Sciences Major Shareholders Opthea Major Shareholders This page (NYSE:PLX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLX Stock Alerts